RecruitingPhase 2NCT07171905
CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease
Studying Von Hippel-Lindau disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- IRCCS Ospedale San Raffaele
- Intervention
- investigating the role of CAIX as target in VHL disease and in VHL-/- tumors.(drug)
- Enrollment
- 38 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2026
Study locations (1)
- IRCCS Ospedale San Raffaele, Milan, Italia, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07171905 on ClinicalTrials.govOther trials for Von Hippel-Lindau disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07405164Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)Merck Sharp & Dohme LLC
- ENROLLING BY INVITATIONNANCT05737602Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau DiseaseMassachusetts General Hospital
- RECRUITINGPHASE2NCT07167329Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL TrialJosé Claudio Casali da Rocha
- RECRUITINGNCT05955014Data Collection Protocol for Patients With Von Hippel Lindau DiseaseM.D. Anderson Cancer Center
- RECRUITINGNCT06194669Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule CellsIRCCS San Raffaele
- RECRUITINGNANCT05424016Propranolol and Von Hippel-Lindau DiseaseAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE2NCT04924075Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)Merck Sharp & Dohme LLC
- ACTIVE NOT RECRUITINGNCT04458935Retrospective Case Series of Trans-scleral Cryotherapy for Retinal HemangioblastomaNational Eye Institute (NEI)